Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Election Impact: Key Senate Committees

Executive Summary

Following the Nov. 8 elections, the power of the incumbency prevailed, and there were few election-related changes to key committee assignments in the Senate Finance Committee, which oversees Medicare, health and tax policy, and in the Senate Health, Education, Labor and Pensions (HELP) panel, which oversees FDA and other health policy issues. Some members may choose to switch assignments once the next Congress convenes in January 2017, however.

You may also be interested in...



Medical Innovation Bills On Fast Track In Congress, But Some Barriers Remain

With an all-Republican House, Senate and administration lined up to lead the government following the 2016 elections, the path is clear for passage of a set of FDA reforms to ease device approvals embedded in a combined House 'Cures' and Senate medical innovation package. It could even happen over the upcoming lame-duck session, before the new administration and Congress take over. But controversy around price-gouging by drug firms still could stymie quick Cures bill passage, an industry attorney predicts. Meanwhile, medtech industry groups plan to seize on the Trump victory as a means to achieve permanent device tax repeal.

Survey Shows Europeans Supplement Responsibly, Favor Vitamin D Especially

The majority of European consumers use dietary supplements and do so responsibly, a recent survey by industry association Food Supplements Europe shows. Reflecting a common concern for well-being and immunity, vitamin D is the most popular supplement ingredient, followed by vitamin C and magnesium. 

Study Offers Support For Biosimilar-To-Biosimilar Switching

A new paper has examined the issue of biosimilar-to-biosimilar switching, concluding that it is a safe and effective clinical practice but highlighting a lack of current health authority regulations or guidance on the subject.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT104075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel